2025 · 4th Quarter (Oct 1 - Dec 31)

OCTAPHARMA USA, INC.

Filed by CORNERSTONE GOVERNMENT AFFAIRS, INC..

Open official filing

Source-reported fields

Filing overview

Type: 4th Quarter - Report
Posted: Jan 12, 2026
Income: $90,000.00
Expenses: Not reported
Registrant: CORNERSTONE GOVERNMENT AFFAIRS, INC.
Client: OCTAPHARMA USA, INC.
Filing UUID: 97a75ed0-fcc6-4698-a784-f7918cd613b5
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

TRD · Trade (domestic/foreign)

Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.

MED · Medical/Disease Research/Clinical Labs

Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.

MAN · Manufacturing

Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.